Related Experiment Video

Updated: Jul 16, 2026

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
10:03

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Published on: November 5, 2019

Post-licensure safety of the meningococcal group C conjugate vaccine

Nick Andrews1, Julia Stowe, Elizabeth Miller

  • 1Statistics Unit, Health Protection Agency, Centre for Infections, London, UK. nick.andrews@hpa.org.uk

Human Vaccines
|February 22, 2007
PubMed

Insights

Meningococcal group C conjugate vaccine (MCCV) did not increase the risk of convulsions or purpura in children. This study found no evidence of adverse events following MCCV immunization.

Area of Science:

  • Pediatric immunology
  • Vaccine safety research
  • Epidemiological studies

Background:

  • Passive surveillance suggested potential risks of convulsions and purpura post-meningococcal group C conjugate vaccine (MCCV).
  • Investigating vaccine safety is crucial for public health and informed immunization policies.

Purpose of the Study:

  • To assess the epidemiological evidence for an increased risk of convulsions and purpura following MCCV administration.
  • To analyze the association between MCCV and specific adverse events in children.

Main Methods:

  • Utilized a self-controlled case-series method to analyze linked hospital admission and vaccination records.
  • Included data from children in South East England (November 1999 - September 2003) for MCCV, DTP, and MMR vaccines.
  • Analyzed 1,715 children with convulsions and 363 with purpura.

Main Results:

  • No increased relative incidence (RI) of convulsions was observed within two weeks post-MCCV across all age groups.
  • No increased RI of purpura was found within four weeks following MCCV vaccination (overall RI: 1.15).
  • Confirmed previously documented increased risks of convulsions and idiopathic thrombocytopenic purpura associated with MMR vaccination.

Conclusions:

  • Meningococcal group C conjugate vaccine (MCCV) is not associated with an increased risk of convulsions or purpura.
  • The study reinforces the safety profile of MCCV, distinguishing its safety from other routine childhood immunizations.
  • Highlights the importance of robust epidemiological methods in vaccine safety surveillance.

More Related Videos

Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes13:53

Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes

Published on: December 19, 2020

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens13:47

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens

Published on: May 19, 2020

Related Concept Videos

Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Streptococcal Pharyngitis01:27

Streptococcal Pharyngitis

Streptococcal pharyngitis, commonly known as “strep throat,” is an acute infection of the oropharyngeal tissues caused by the Gram‑positive Group A Streptococcus (Streptococcus pyogenes). Transmission occurs primarily through respiratory droplets expelled during coughing, sneezing, or talking.Mechanisms of Host Entry and Immune EvasionUpon entering the host, S. pyogenes adheres to the mucosal epithelial cells of the pharynx via surface proteins, notably lipoteichoic acid and the antiphagocytic...